These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1561227)

  • 1. Bioconversion of tamoxifen by microbes.
    el-Sharkawy SH
    Pharm Acta Helv; 1992; 67(1):15-9. PubMed ID: 1561227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of polyethylene glycol and acetone on the in vitro biotransformation of tamoxifen and alprazolam by human liver microsomes.
    Cotreau-Bibbo MM; von Moltke LL; Greenblatt DJ
    J Pharm Sci; 1996 Nov; 85(11):1180-5. PubMed ID: 8923322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidation of tamoxifen by human flavin-containing monooxygenase (FMO) 1 and FMO3 to tamoxifen-N-oxide and its novel reduction back to tamoxifen by human cytochromes P450 and hemoglobin.
    Parte P; Kupfer D
    Drug Metab Dispos; 2005 Oct; 33(10):1446-52. PubMed ID: 15987777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial conversion products of leptomycin B.
    Kuhnt M; Bitsch F; Ponelle M; Sanglier JJ; Wang Y; Wolff B
    Appl Environ Microbiol; 1998 Feb; 64(2):714-20. PubMed ID: 9464413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that the catechol 3,4-Dihydroxytamoxifen is a proximate intermediate to the reactive species binding covalently to proteins.
    Dehal SS; Kupfer D
    Cancer Res; 1996 Mar; 56(6):1283-90. PubMed ID: 8640815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of 4-hydroxy-N-desmethyltamoxifen as a metabolite of tamoxifen in human bile.
    Lien EA; Solheim E; Kvinnsland S; Ueland PM
    Cancer Res; 1988 Apr; 48(8):2304-8. PubMed ID: 3349495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acidic metabolites of tamoxifen. Aspects of formation and fate in the female rat.
    Ruenitz PC; Bai X
    Drug Metab Dispos; 1995 Sep; 23(9):993-8. PubMed ID: 8565791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbial N-demethylation: biotransformation and recovery of a drug metabolite.
    Davis BL; Liu MS; Hanson RL; Parker WL; Patel RN
    Biotechnol Appl Biochem; 2009 Jun; 53(Pt 2):133-7. PubMed ID: 18699775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen metabolite isomer separation and quantification by liquid chromatography-tandem mass spectrometry.
    Jaremko M; Kasai Y; Barginear MF; Raptis G; Desnick RJ; Yu C
    Anal Chem; 2010 Dec; 82(24):10186-93. PubMed ID: 21086978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiological transformation of (+/-)-flavanone and (+/-)-isoflavanone.
    Ibrahim AR; Abul-Hajj YJ
    J Nat Prod; 1990; 53(3):644-56. PubMed ID: 2213034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excretion of hydroxylated metabolites of tamoxifen in human bile and urine.
    Kisanga ER; Mellgren G; Lien EA
    Anticancer Res; 2005; 25(6C):4487-92. PubMed ID: 16334131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoxifen, a secondary metabolite of tamoxifen, and 4-OH-tamoxifen induce similar changes in global gene expression patterns in MCF-7 breast cancer cells.
    Lim YC; Li L; Desta Z; Zhao Q; Rae JM; Flockhart DA; Skaar TC
    J Pharmacol Exp Ther; 2006 Aug; 318(2):503-12. PubMed ID: 16690721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth.
    Coezy E; Borgna JL; Rochefort H
    Cancer Res; 1982 Jan; 42(1):317-23. PubMed ID: 7053859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative measurement of 4-hydroxy tamoxifen in human plasma and mammary tumours by combined gas chromatography/negative chemical ionization mass spectrometry.
    Girault J; Istin B; Fourtillan JB
    Biol Mass Spectrom; 1993 Jul; 22(7):395-402. PubMed ID: 8357855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biotransformation of valdecoxib by microbial cultures.
    Keshetti S; Ciddi V
    J Microbiol Biotechnol; 2010 Apr; 20(4):809-16. PubMed ID: 20467258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiological hydroxylation of cinerone to cinerolone.
    Berger J; Tabenkin B; LeMahieu RA; Kierstead RW
    Appl Microbiol; 1969 May; 17(5):714-7. PubMed ID: 5785954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel metabolites of warfarin produced by Beauveria bassiana and Streptomyces rimosus: a novel application of hplc-nmr.
    Cannell RJ; Rashid T; Ismail IM; Sidebottom PJ; Knaggs AR; Marshall PS
    Xenobiotica; 1997 Feb; 27(2):147-57. PubMed ID: 9058529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative metabolic study between two selective estrogen receptor modulators, toremifene and tamoxifen, in human liver microsomes.
    Watanabe M; Watanabe N; Maruyama S; Kawashiro T
    Drug Metab Pharmacokinet; 2015 Oct; 30(5):325-33. PubMed ID: 26423799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a quantitative assay for the determination of tamoxifen and its five main phase I metabolites in human serum using liquid chromatography coupled with tandem mass spectrometry.
    Teunissen SF; Jager NG; Rosing H; Schinkel AH; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jun; 879(19):1677-85. PubMed ID: 21543272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative monitoring of tamoxifen in human plasma extended to 40 metabolites using liquid-chromatography high-resolution mass spectrometry: new investigation capabilities for clinical pharmacology.
    Dahmane E; Boccard J; Csajka C; Rudaz S; Décosterd L; Genin E; Duretz B; Bromirski M; Zaman K; Testa B; Rochat B
    Anal Bioanal Chem; 2014 Apr; 406(11):2627-40. PubMed ID: 24633563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.